Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: A meta-analysis

Age

Volumn 33, Issue 3, 2011, Pages 421-431

  Sharif, Pooneh Salari ^a   Nikfar, Shekoufeh ^b,c   Abdollahi, Mohammad ^b,d,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone specific alkaline posphatase; Desoxypyridinoline; Meta analysis; Osteoporosis; Oxidative stress; Phytoestrogens; Pyridinoline; Soy isoflavone

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; PHYTOESTROGEN; PLACEBO; PYRIDINOLINE;

ARTICLE; BLOOD LEVEL; BONE DENSITY; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; META ANALYSIS; OSSIFICATION; OSTEOLYSIS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTMENOPAUSE OSTEOPOROSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT DURATION; URINE LEVEL;

BIOLOGICAL MARKERS; BONE RESORPTION; FEMALE; HUMANS; OSTEOGENESIS; OSTEOPOROSIS; PHYTOESTROGENS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT OUTCOME;

EID: 80655141715     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-010-9180-6     Document Type: Article

References (42)

1. Abdollahi M, Larijani B, Rahimi R, Salari P (2005) Role of oxidative stress in osteoporosis. Therapy 2(5):787-796 (Pubitemid 41447768)
2. Albertazzi P, Steel SA, Bottazzi M (2005) Effect of pure genistein on bone markers and hot flashes. Climacteric 8:371-379 (Pubitemid 41617486)
3. Anderson JJ, Ambrose WW, Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217:345-350
4. Anonymous. Prevention and management of osteoporosis. A report of a WHO scientific group 2003. http://whqlibdoc. who.int/trs/WHO-TRS-921.pdf
5. Arjmandi BH, Khalil DA, Smith BJ et al (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reduc-ing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88(3):1048-1054 (Pubitemid 36337755)
6. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79:326-333 (Pubitemid 41095988)
7. Branca F (2003) Dietary phyto-oestrogens and bone health. Proc Nutr Soc 62:877-887 (Pubitemid 38004985)
8. Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ (2001) Soybean ethanol extract increases the function of osteo-blastic MC3T3-E1. Phytochemistry 56:733-739 (Pubitemid 32267732)
9. Cook A, Pennington G (2002) Phytoestrogen and multiple vitamin/mineral effects on bone mineral density in early postmenopausal women: a pilot study. J Women's Health Gend Based Med 11(1):53-60
10. Crisafulli A, Altavilla D, Squadrito G et al (2004) Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor ?B ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 89:188-192 (Pubitemid 38183880)
11. Dalais FS, Ebeling PR, Kotsopoulos D, Mc Grath BP, Teede HJ (2003) The effects of soy protein containing isoflavones on lipids and indices ofbone resorption in postmenopausal women. Clin Endocrinol 58(6):704-709 (Pubitemid 36702729)
12. Devareddy L, Khalil DA, Smith BJ et al (2006) Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 38:686-693
13. Evans EM, Racette SB, Van Pelt RE, Peterson LR, Villareal DT (2007) Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women. Menopause 14(3 Pt 1):481-488
14. Farley JR, Chesnut CH 3rd, Baylink DJ (1981) Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin. Clin Chem 27:2002-2007 (Pubitemid 12194428)
15. Garnero P, Sornay-Rendu E, Chapuy MC et al (1996) Increased bone turnover in late postmenopausal women is a major determinant ofosteoporosis. J Bone Miner Res 11:337-349 (Pubitemid 26076383)
16. Gunja-Smith Z, Boucek RJ (1981) Collagen cross-linking compounds in human urine. Biochem J 197:759-762 (Pubitemid 11031134)
17. Harkness LS, Fiedler K, Sehgal AR, Oravec D, Lerner E (2004) Decreased bone resorption with soy isoflavone supple-mentation in postmenopausal women. J Womens Health 13(9):1000-1007 (Pubitemid 40017338)
18. Hidaka S, Okamoto Y, Miyazaki K, Uesugi T (2003) Evaluation of a soybean product Fujiflavone P40 as an antiosteoporotic agent in rats. Phytother Res 17:112-119 (Pubitemid 36262257)
19. Hulley S, Grady D, Bush T et al (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Re-search Group. JAMA 280:605-613 (Pubitemid 28502636)
20. Kreijkamp-Kaspers S, Kok L, Grobbee DE et al (2004) Effect of soy protein containing isoflavones on cognitive func-tion, bone mineral density, and plasma lipids in postmen-opausal women. JAMA 292:65-74 (Pubitemid 38923795)
21. Kritz-Silverstein D, Goodman-Gruen DL (2002) Usual dietary isoflavone intake, bone mineral density, and bone metab-olism in postmenopausal women. J Women's Health Gend Based Med 11(1):69-78
22. Liu J, Ho SC, Su Y, Chen W, Zhang C, Chen Y (2009) Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 44:948-953
23. Ma DF, Qin LQ, Wang PY, Katoh R (2008) Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of ran-domized controlled trials. Eur J Clin Nutr 62:155-161 (Pubitemid 351234248)
24. Middleton ET, Steel SA (2007) The effects of short-term hormone replacement therapy on long-term bone mineral density Climacteric 10:257-263 (Pubitemid 46752433)
25. Morabito N, Crisafulli A, Vergara C et al (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17 (10):1904-1912
26. Picherit C, Bennetau-Pelissero C, Chanteranne B et al (2001) Soybean isoflavones dose-dependently reduce bone turn-over but do not reverse established osteopenia in adult ovariectomizedrats. J Nutr 131:723-728 (Pubitemid 32199136)
27. Riggs BL, Melton LJ 3rd (2002) Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density J Bone Miner Res 17:11-14 (Pubitemid 33150991)
28. Rossouw JE, Anderson GL, Prentice RL, Writing Group for the Women's Health Initiative Investigators et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Wom-en's Health Initiative randomized controlled trial. JAMA 288:321-333 (Pubitemid 34761611)
29. Salari P, Abdollahi M (2009) Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets 8(3):169-175
30. Salari P, Larijani B, Abdollahi M (2008a) Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 5(2):215-222 (Pubitemid 351513513)
31. Salari P, Rezaie A, Larijani B, Abdollahi M (2008b) A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 14(3):RA37-RA44
32. Salari P, Asalforoush M, Ameri F, Larijani B, Abdollahi M (2010) The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a random-ized clinical trial. Age. doi:10.1007/s11357-009- 9122-3
33. Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108-1112 (Pubitemid 38668990)
34. Srivastava AK, Vliet EL, Lewiecki EM et al (2005) Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin 21:1015-1026 (Pubitemid 41032690)
35. Suh KS, Koh G, Park CY et al (2003) Soybean isoflavones inhibit tumor necrosis factor-α-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 63:209-215 (Pubitemid 36560140)
36. Uesugi T, Fukui Y, Yamori Y (2002) Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 21(2):97-102 (Pubitemid 38639154)
37. Uesugi T, Toda T, Okuhira T, Chen JT (2003) Evidence of estrogenic effect by the three-month-intervention of isoflavone on vaginal maturation and bone metabolism in early postmenopausal women. Endocr J 50(5):613-619 (Pubitemid 37442837)
38. Wangen KE, Duncan AM, Merz-Demlow BE et al (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endo-crinol Metab 85(9):3043-3048
39. 41Ca methodology J Clin Endocrinol Metab 94:3798-3805
40. Yamori Y Moriguchi EH, Teramoto T et al (2002) Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J Am Coll Nutr 21(6):560-563 (Pubitemid 36026268)
41. Ye YB, Tang XY, Verbruggen MA, Su YX (2006) Soy isoflavones attenuate bone loss in early postmenopausal Chinese women. A single-blind randomized. Placebo-controlled trial. Eur J Nutr 45:327-334 (Pubitemid 44386851)
42. Zhang G, Qin L, Shi Y (2007) Epimedium-derived phytoes-trogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res 22(7):1072-1079 (Pubitemid 351343696)